rs267607048
Variant summary
The NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The gene SHOC2 is a known oncogene (CancerMine: 2 oncogene, 1 driver citations). The gene SHOC2 is a cancer driver gene (CancerMine: 2 oncogene, 1 driver citations). The variant allele was found at a cumulative frequency of 0.00000342 (AC=5) in the gnomAD database across 1,460,838 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000147. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.49). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000605107: Functional characterization of the p.Ser2Gly protein indicates enhanced myristoylation, and aberrant targeting of the SHOC2 to the cell membrane in the absence of growth factor signaling (Cordeddu 2009). PMID:19684605" and additional evidence is available in ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S2T: Uncertain_significance (ClinVar VariationId 2265459, 1 star) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). The variant has been observed in cBioPortal in 3 samples across 2 studies and 3 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_007373.4 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndrome-like disorder with loose anagen hairInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Noonan syndrome-like disorder with loose anagen hair 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- cardiofaciocutaneous syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | CGI exact DNA-change oncogenic — Strong (O1); O1 contributing sources (4.0 pts): CGI (Cancer Genome Interpreter) | ||
| O3Absent or very rare in population | Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000015 — very rare (O3 supporting [+1]) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_007373.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SHOC2 | MANE Select | c.4A>G p.Ser2Gly | missense | Exon 2 of 9 | Prot: NP_031399.2 | |
SHOC2 | c.4A>G p.Ser2Gly | missense | Exon 2 of 9 | Prot: NP_001311265.1 UniProt: | ||
SHOC2 | c.4A>G p.Ser2Gly | missense | Exon 3 of 10 | Prot: NP_001311266.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SHOC2 | TSL:1MANE Select | c.4A>G p.Ser2Gly | missense | Exon 2 of 9 | Prot: ENSP00000358464.5 UniProt: | |
SHOC2 | c.4A>G p.Ser2Gly | missense | Exon 3 of 10 | Prot: ENSP00000510210.1 UniProt: | ||
SHOC2 | c.4A>G p.Ser2Gly | missense | Exon 2 of 9 | Prot: ENSP00000509273.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | AF: 0.00000657 | AC:1 | Hom:0 | AN:152166 | Cov:32 |
GnomAD4 exome | AF: 0.00000342 | AC:5 | Hom:0 | AN:1460838 | Cov:31 |
GnomAD4 genome | AF: 0.00000657 | AC:1 | Hom:0 | AN:152166 | Cov:32 |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00000979 | AC:2 | Hom:0 | AN:204292 | |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 21 | |
AlphaMissense | Benign | 0.11 | |
BayesDel_addAF | Uncertain | 0.16 | D |
BayesDel_noAF | Uncertain | -0.010 | |
CADD | Uncertain | 25 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Benign | 0.17 | T |
Eigen | Uncertain | 0.51 | |
Eigen_PC | Uncertain | 0.58 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
GPN-Star LLR | N/A | -7.4 | |
GPN-Star score | N/A | 7.4 | |
LIST_S2 | Benign | 0.76 | T |
M_CAP | Benign | 0.023 | T |
MetaRNN | Pathogenic | 0.85 | D |
MetaSVM | Benign | -0.87 | T |
Mutation Taster | N/A | 13/87 | disease causing (ClinVar) |
MutationAssessor | Benign | 1.9 | M |
PhyloP100 | Pathogenic | 8.5 | |
popEVE | Benign | -3.3 | |
PrimateAI | Uncertain | 0.71 | T |
PROVEAN | Benign | -0.35 | N |
REVEL | Uncertain | 0.39 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Benign | 0.60 | T |
Varity_R | N/A | 0.44 | |
VESM-3B | Benign | -4.3 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.